Fundz

GemVax & KAEL Appoints Lee Jae-hong as Chief Medical Officer

PRIVATENov 04, 2026
New to company“has hired Lee Jae-hong”

Position

Chief Medical Officer

Company

GemVax & KAEL

Lee Jae-hong
BiotechnologyHealth CareTherapeuticsBiopharma

Description

GemVax & KAEL has hired Lee Jae-hong, a medical doctor and clinical expert in neurodegenerative diseases, as chief medical officer. Lee will oversee clinical development and operations for the company's bio division, enhancing their capabilities in domestic and overseas clinical trials.

Who to call at GemVax & KAEL, and when

A new leader at GemVax & KAEL brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day GemVax & KAEL raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GemVax & KAEL, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GemVax & KAEL. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GemVax & KAEL

About

GemVax & KAEL is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. The company aims to enhance clinical development capabilities and expand its pipeline for progressive supranuclear palsy and amyotrophic lateral sclerosis. With a commitment to innovation, GemVax & KAEL strives to provide effective treatment options for patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GemVax & KAEL changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Moonhwan
Senior decision-maker at this company
••••••••@••••••••

See Moonhwan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for GemVax & KAEL's next move

Learn about Strategic plan

GemVax & KAEL changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.